Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie L Stocker

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
The Pharmacogenomics Journal|October 22, 2025
Evaluation of experiential teaching approaches to enhance pharmacy students' confidence and knowledge in pharmacogenomicsRuby Soueid, Toni J F Michael, Pete Yeap, et al.
Nephrology (Carlton, Vic.)|April 16, 2024
The impact of peritoneal dialysis on oxypurinol and urate elimination in people with goutLuke C Wilson, Jacob Ward, Daniel F B Wright, et al.
ACR Open Rheumatology|April 9, 2024
Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility StudyToni J F Michael, Daniel F B Wright, Jian S Chan, et al.
British Journal of Clinical Pharmacology|June 8, 2022
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptionsMatthew J Coleshill, Richard O Day, Karson Tam, et al.
Clinical Chemistry|April 28, 2023
Analytical and Non-Analytical Variation May Lead to Inappropriate Antimicrobial Dosing in Neonates: An In Silico StudyThi A Nguyen, Ranita Kirubakaran, Hayley B Schultz, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2020
Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software packageKanika Chaudhri, Sophie L Stocker, Kenneth M Williams, et al.
Clinical Pharmacokinetics|December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation StudyMelanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
Arthritis Research & Therapy|August 21, 2012
Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patientsDiluk R W Kannangara, Sheena N Ramasamy, Praveen L Indraratna, et al.
British Journal of Clinical Pharmacology|April 18, 2013
Understanding the dose-response relationship of allopurinol: predicting the optimal dosageGarry G Graham, Diluk R W Kannangara, Sophie L Stocker, et al.
British Journal of Clinical Pharmacology|September 3, 2024
Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
The Pharmacogenomics Journal|October 22, 2025
Evaluation of experiential teaching approaches to enhance pharmacy students' confidence and knowledge in pharmacogenomicsRuby Soueid, Toni J F Michael, Pete Yeap, et al.
Nephrology (Carlton, Vic.)|April 16, 2024
The impact of peritoneal dialysis on oxypurinol and urate elimination in people with goutLuke C Wilson, Jacob Ward, Daniel F B Wright, et al.
ACR Open Rheumatology|April 9, 2024
Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility StudyToni J F Michael, Daniel F B Wright, Jian S Chan, et al.
British Journal of Clinical Pharmacology|June 8, 2022
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptionsMatthew J Coleshill, Richard O Day, Karson Tam, et al.
Clinical Chemistry|April 28, 2023
Analytical and Non-Analytical Variation May Lead to Inappropriate Antimicrobial Dosing in Neonates: An In Silico StudyThi A Nguyen, Ranita Kirubakaran, Hayley B Schultz, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2020
Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software packageKanika Chaudhri, Sophie L Stocker, Kenneth M Williams, et al.
Clinical Pharmacokinetics|December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation StudyMelanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
Arthritis Research & Therapy|August 21, 2012
Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patientsDiluk R W Kannangara, Sheena N Ramasamy, Praveen L Indraratna, et al.
British Journal of Clinical Pharmacology|April 18, 2013
Understanding the dose-response relationship of allopurinol: predicting the optimal dosageGarry G Graham, Diluk R W Kannangara, Sophie L Stocker, et al.
British Journal of Clinical Pharmacology|September 3, 2024
Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, et al.
Pageof 10